Showing results (581-590 of 812) with videos related to
Sort By:
Pageof 82
Wiener Klinische Wochenschrift|June 20, 2018
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic functionBernhard Scheiner, Paul René Stammet, Sebastian Pokorny, et al.Alimentary Pharmacology & Therapeutics|September 24, 2025
Research Communication: The Cumulated Spontaneous Portosystemic Shunts (SPSS) Area Decreases After TIPS and Impacts on PrognosisMarlene Hintersteininger, Theresa Müllner-Bucsics, Susanna Riegler, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2025
Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With CirrhosisNina Dominik, Benedikt Simbrunner, Bernhard Scheiner, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2016
von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapyKaroline Rutter, Alexandra Etschmaier, Monika Ferlitsch, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 3, 2020
Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver diseaseBenedikt Simbrunner, Rodrig Marculescu, Bernhard Scheiner, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 9, 2026
Changes in SSM Assessed via 100 Hz-VCTE Are Associated With Acute HVPG-Response to i.v. Propranolol: A European Multicentre StudyPaul Thöne, Dario Saltini, Joana Calvão, et al.Journal of Hepatology|April 17, 2017
Impact of higher-order heme degradation products on hepatic function and hemodynamicsRaphael A Seidel, Thierry Claudel, Franziska A Schleser, et al.Cell Death & Disease|October 27, 2017
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosisKatharina Staufer, Mirko Dengler, Heidemarie Huber, et al.Hepatology Communications|July 5, 2021
COVID-19-Related Downscaling of In-Hospital Liver Care Decreased Patient Satisfaction and Increased Liver-Related MortalityLukas Hartl, Georg Semmler, Benedikt Silvester Hofer, et al.JHEP Reports : Innovation in Hepatology|March 6, 2023
Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver diseaseLorenz Balcar, Julia Krawanja, Bernhard Scheiner, et al.Pageof 82